Literature DB >> 23277357

Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis.

Jason J Northey1, Zhifeng Dong, Elaine Ngan, Andrew Kaplan, W Rod Hardy, Tony Pawson, Peter M Siegel.   

Abstract

The ErbB2 and TGFβ signaling pathways cooperate to promote the migratory, invasive, and metastatic behavior of breast cancer cells. We previously demonstrated that ShcA is necessary for these synergistic interactions. Through a structure/function approach, we now show that the phosphotyrosine-binding, but not the Src homology 2, domain of ShcA is required for TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells. We further demonstrate that the tyrosine phosphorylation sites within ShcA (Tyr(239)/Tyr(240) and Tyr(313)) transduce distinct and non-redundant signals that promote these TGFβ-mediated effects. We demonstrate that Grb2 is required specifically downstream of Tyr(313), whereas the Tyr(239)/Tyr(240) phosphorylation sites require the Crk adaptor proteins to augment TGFβ-induced migration and invasion. Furthermore, ShcA Tyr(313) phosphorylation enhances tumor cell survival, and ShcA Tyr(239)/Tyr(240) signaling promotes endothelial cell recruitment into ErbB2-expressing breast tumors in vivo, whereas all three ShcA tyrosine residues are required for efficient breast cancer metastasis to the lungs. Our data uncover a novel ShcA-dependent signaling axis downstream of TGFβ and ErbB2 that requires both the Grb2 and Crk adaptor proteins to increase the migratory and invasive properties of breast cancer cells. In addition, signaling downstream of specific ShcA tyrosine residues facilitates the survival, vascularization, and metastatic spread of breast tumors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23277357      PMCID: PMC3576125          DOI: 10.1074/jbc.M112.424804

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Crk synergizes with epidermal growth factor for epithelial invasion and morphogenesis and is required for the met morphogenic program.

Authors:  Louie Lamorte; Sonia Rodrigues; Monica Naujokas; Morag Park
Journal:  J Biol Chem       Date:  2002-07-23       Impact factor: 5.157

2.  The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.

Authors:  P van der Geer; S Wiley; G D Gish; T Pawson
Journal:  Curr Biol       Date:  1996-11-01       Impact factor: 10.834

Review 3.  The PTB domain: a new protein module implicated in signal transduction.

Authors:  P van der Geer; T Pawson
Journal:  Trends Biochem Sci       Date:  1995-07       Impact factor: 13.807

4.  Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions.

Authors:  Louie Lamorte; Isabelle Royal; Monica Naujokas; Morag Park
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

5.  Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor.

Authors:  H Khoury; D L Dankort; S Sadekova; M A Naujokas; W J Muller; M Park
Journal:  Oncogene       Date:  2001-02-15       Impact factor: 9.867

6.  Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules.

Authors:  Takeshi Nakamura; Misako Komiya; Noriko Gotoh; Shinichi Koizumi; Masabumi Shibuya; Nozomu Mori
Journal:  Oncogene       Date:  2002-01-03       Impact factor: 9.867

7.  Multiple ErbB-2/Neu Phosphorylation Sites Mediate Transformation through Distinct Effector Proteins.

Authors:  D Dankort; N Jeyabalan; N Jones; D J Dumont; W J Muller
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

8.  A novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL-3.

Authors:  N Gotoh; A Tojo; M Shibuya
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

9.  Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.

Authors:  A E Salcini; J McGlade; G Pelicci; I Nicoletti; T Pawson; P G Pelicci
Journal:  Oncogene       Date:  1994-10       Impact factor: 9.867

10.  The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.

Authors:  M Rozakis-Adcock; R Fernley; J Wade; T Pawson; D Bowtell
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

View more
  13 in total

1.  Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.

Authors:  Huocong Huang; Robert A Svoboda; Audrey J Lazenby; Jintana Saowapa; Nina Chaika; Ke Ding; Margaret J Wheelock; Keith R Johnson
Journal:  J Biol Chem       Date:  2016-09-07       Impact factor: 5.157

2.  Cyanobacterial bioactive compound EMTAHDCA recovers splenomegaly, affects protein profile of E. coli and spleen of lymphoma bearing mice.

Authors:  Shashank Kumar Maurya; Balkrishna Tiwari; Sindhunath Chakraborty; Ekta Verma; Rajnikant Mishra; Arun Kumar Mishra
Journal:  Mol Biol Rep       Date:  2019-04-12       Impact factor: 2.316

3.  GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis.

Authors:  G Maric; M G Annis; Z Dong; A A N Rose; S Ng; D Perkins; P A MacDonald; V Ouellet; C Russo; P M Siegel
Journal:  Oncogene       Date:  2015-03-16       Impact factor: 9.867

4.  The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation.

Authors:  Alex Kiepas; Elena Voorand; Julien Senecal; Ryuhjin Ahn; Matthew G Annis; Kévin Jacquet; George Tali; Nicolas Bisson; Josie Ursini-Siegel; Peter M Siegel; Claire M Brown
Journal:  J Biol Chem       Date:  2020-04-16       Impact factor: 5.157

5.  Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.

Authors:  Chanèle Cyr-Depauw; Jason J Northey; Sébastien Tabariès; Matthew G Annis; Zhifeng Dong; Sean Cory; Michael Hallett; Jonathan P Rennhack; Eran R Andrechek; Peter M Siegel
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

6.  High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer.

Authors:  Rumeysa Ciftci; Faruk Tas; Ceren Tilgen Yasasever; Ece Aksit; Senem Karabulut; Fatma Sen; Serkan Keskin; Leyla Kilic; Ibrahim Yildiz; Hamza Ugur Bozbey; Derya Duranyildiz; Sezai Vatansever
Journal:  Tumour Biol       Date:  2014-04-17

Review 7.  Targeting metastasis.

Authors:  Patricia S Steeg
Journal:  Nat Rev Cancer       Date:  2016-04       Impact factor: 60.716

Review 8.  Emerging roles for LPP in metastatic cancer progression.

Authors:  Elaine Ngan; Alex Kiepas; Claire M Brown; Peter M Siegel
Journal:  J Cell Commun Signal       Date:  2017-10-13       Impact factor: 5.782

9.  Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.

Authors:  Susanne Schüler-Toprak; Julia Häring; Elisabeth C Inwald; Christoph Moehle; Olaf Ortmann; Oliver Treeck
Journal:  BMC Cancer       Date:  2016-12-21       Impact factor: 4.430

10.  Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions.

Authors:  Véronique Pomerleau; Mélissa Landry; Jimmy Bernier; Pierre H Vachon; Caroline Saucier
Journal:  BMC Cancer       Date:  2014-04-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.